Phase 3 Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Compare the Efficacy and Safety of Lenalidomide (CC-5013) Plus R-CHOP Chemotherapy (R2-CHOP) Versus Placebo Plus R-CHOP Chemotherapy in Subjects with Previously Untreated Activated B-cell Type Diffuse Large B-cell Lymphoma

UCI-14-84
NCT02285062
Cancer - Hodgkin's Lymphoma, Cancer - Leukemia, other, Cancer - Lymphoid Leukemia, Cancer - Multiple Myeloma, Cancer - Myeloid and Monocytic Leukemia, Cancer - Non-Hodgkin's Lymphoma, Cancer - Other Hematopoietic
Deepa Jeyakumar
Open
Treatment
Adriamycin, Cyclophosphamide, Cytoxan, Doxorubicin, Lenalidomide, MabThera, Oncovin, Placebo, Prednisone, Rituximab, Vincristine
III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.